Therefore, we employed the PTEN and TP53 allele cut-off to this larger cohort of cases, stratifying the prostate cancer TCGA cohort based on manually curated calls for PTEN and TP53 using the same computational pipeline as our own analysis. The gene discussed is TP53; the disease is prostate carcinoma.